Piramal Healthcare UK Limited
Manufacture of pharmaceutical preparations · Morpeth
ActiveUnited KingdomIncorporated 2005Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£9,631,140
Cash
£238,000
Turnover
£94,880,189
Profit / loss
−£25,030,601
Current assets
£45,305,554
Creditors < 1 year
£101,754,971
Equity
£9,631,140
Average employees
718
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | £9,631,140 | £34,661,741 |
| Equity | £9,631,140 | £34,661,741 |
| Share capital | £23,232,501 | £23,232,501 |
| Retained earnings | −£13,601,361 | £11,429,240 |
| Assets | ||
| Fixed assets | £88,865,847 | £97,573,502 |
| Intangible assets | £4,797,201 | £11,484,621 |
| Property, plant & equipment | £84,068,646 | £86,088,881 |
| Current assets | £45,305,554 | £57,741,139 |
| Cash at bank | £238,000 | £426,526 |
| Debtors | £15,743,584 | £26,846,471 |
| Stock | £29,323,970 | £30,468,142 |
| Liabilities | ||
| Creditors within one year | £101,754,971 | £91,459,448 |
| Creditors after one year | £22,785,290 | £29,193,452 |
| Capital commitments | £1,250,101 | — |
| Net current assets | −£56,449,417 | −£33,718,309 |
| Assets less current liabilities | £32,416,430 | £63,855,193 |
| Profit & loss | ||
| Turnover | £94,880,189 | £93,271,417 |
| Cost of sales | £40,334,494 | £43,073,461 |
| Gross profit | £54,545,695 | £50,197,956 |
| Distribution costs | £978,895 | £1,335,449 |
| Administrative expenses | £77,384,263 | £74,029,315 |
| Other operating income | £4,567,125 | £4,331,757 |
| Operating profit | −£19,250,338 | −£20,835,051 |
| Interest payable | £5,314,873 | £4,152,129 |
| Profit before tax | −£24,565,211 | −£24,987,180 |
| Tax | −£465,390 | −£76,853 |
| Profit / loss | −£25,030,601 | −£25,064,033 |
| Operating costs | ||
| Audit fees | £55,950 | £54,200 |
| People & pay | ||
| Average employees | 718 | 697 |
| Directors' remuneration | £939,175 | £855,229 |
| Highest paid director | £374,476 | £265,960 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- KNAV Limited
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Piramal Dutch Holdings N.V.
- Ultimate parent
- Piramal Pharma Limited
- Accounts
- FRS 102
- Approved
- 2026-04-23
Subsidiaries (1)
- Piramal Healthcare Pension Trustees Limited · 100%
Turnover by segment (5)
- Sale of goods: 68,672,176 (2025-12-31)
- Rendering of services: 26,208,013 (2025-12-31)
- UK: 1,595,407 (2025-12-31)
- Europe: 43,994,594 (2025-12-31)
- Rest of world: 49,290,188 (2025-12-31)
Related parties (4)
- Piramal Healthcare Pension Trustees Limited · sole subsidiary · investment
- Piramal Healthcare Pension Trustees Limited · fellow group undertaking · unsecured loans due · £61,379,863
- Piramal Corporate Services Limited · entity controlled by members of the Key Management Personnel of Piramal Pharma Limited · royalty charges incurred · £692,397
- Piramal Corporate Services Limited · entity controlled by members of the Key Management Personnel of Piramal Pharma Limited · amount outstanding, included in amounts due to fellow group undertakings · £331,519
Borrowings (4)
- Bank overdrafts · 132,439 · secured on secured by a fixed charge over the company’s freehold and leasehold property
- Other borrowings (invoice financing arrangement with a bank) · - · interest free for remaining amounts · repayable on demand · secured on unsecured
- Bank borrowings due within one year · 1,680,000 · due within one year · secured on guarantee provided by Piramal Pharma Limited
- Bank loan · £16.8m · 1.990% per annum over the Bank of England Base Rate · quarterly instalments commencing in December 2024; final repayment due in December 2030 · secured on Standard Security over the leasehold property at the company’s Grangemouth site
Share classes (1)
- 23,232,501 Ordinary shares of £1 each of £1
Contingent liabilities (2)
- Guarantee by the bank in favour of HM Revenue & Customs for £703,790.
- A guarantee by the bank in favour of HSBC Bank USA N.A. for $2,000,000 towards the overdraft facility taken by a fellow group undertaking.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
5 outstanding chargesProperty · created 2023-01-18
—
OutstandingProperty · created 2022-06-17
—
OutstandingFixed · created 2014-10-08
—
OutstandingFixed · created 2014-09-30
—
OutstandingAll Assets · created 2010-12-17
All monies
OutstandingShow 5 satisfied / released
Fixed · created 2014-09-23 · satisfied 2026-02-04
—
SatisfiedAll Assets · created 2014-09-22 · satisfied 2026-02-04
—
SatisfiedAll Assets · created 2006-02-13
All monies
Part SatisfiedFloating · created 1999-06-30 · satisfied 2006-04-01
All monies
SatisfiedAll Assets · created 2004-05-14 · satisfied 2006-04-01
All monies
Satisfied